Table 1 Fasting blood glucose of experimental animals at selected stages following streptozotocin (STZ) induction (35 mg/kg body weight) in all diabetic groups, including the negative control.

Normal control

82.17 ± 2.99^{a, b}

82.00 ± 2.37^a

80.00 ± 1.41^a

81.67 ± 2.34^a

80.67 ± 1.63 ^a

Negative control (STZ-induced, untreated)

82.33 ± 1.21^{a, b}

330.33 ± 19.05^c

255.67 ± 12.80^b

276.33 ± 25.26^e

281.50 ± 17.33^e

Metformin treated (500mg)

85.17 ± 1.94^b

280.00 ± 16.30^b

276.83 ± 21.18^c

156.83 ± 13.47^b

102.17 ± 7.08^b

WMJ treated (200mg)

81.83 ± 3.55^{a, b}

302.17 ± 44.12^b

250.00 ± 4.94^b

227.50 ± 3.62^d

198.17 ± 3.76^d

WMJ treated (500mg)

84.00 ± 0.89^{a, b}

365.83 ± 4.02^d

262.67 ± 6.65^b

231.50 ± 3.39^d

178.83 ± 6.97^c

WMJ treated (1000mg)

81.17 ± 1.17^a

298.83 ± 22.05^b

252.00 ± 5.90^b

177.17 ± 0.98^c

109.67 ± 2.07^b